Nutra Pharma (NPHC) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Nutra Pharma Corp   (NPHC)


Nutra Pharma 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



NPHC Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change -59.23 %
Seq. Revenue Change 26.49 %
Revenue In Millions $0.03
Gross Profit Margin 26.6 %
Gross Profit Margin Total Ranking # 1018
Gross Profit In Millions $0.01
Y / Y Gross Profit Change -87.88 %
Seq. Gross Profit Change -51.69 %


Commenting Second Quarter 2026 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 26.6 % due to increase in Cost of Sales and despite Revenue increase of 26.49 % to $0 millions.
Company's Gross Profit Margin in II. Quarter, was lower than company average.


Observing second quarter 2026 results within Legal Cannabis industry 5 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 1018.
Learn about Gross Margin
NPHC's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Legal Cannabis Industry # 6
Consumer Non Cyclical Sector # 18
Overall # 1010

Gross Profit Margin Statistics
High Average Low
94.26 % 66.66 % 4.76 %
(Sep 30 2024)   (Mar 31 2023)




Other Gross Profit Margin Profitability Ratios
NPHC's Cumulative Gross Profit Margin
Legal Cannabis Industry Gross Profit Margin Trends and Statistics
Consumer Non Cyclical Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NPHC's Gross Profit Margin Profitability versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NPHC's Competitors
Gross Profit Margin Profit Margin for Nutra Pharma 's Suppliers
Gross Profit Margin Profit Margin for NPHC's Customers

You may also want to know
NPHC's Annual Growth Rates NPHC's Profitability Ratios NPHC's Asset Turnover Ratio NPHC's Dividend Growth
NPHC's Roe NPHC's Valuation Ratios NPHC's Financial Strength Ratios NPHC's Gross Profit Growth
NPHC's Roa NPHC's Inventory Turnover Ratio NPHC's Growth Rates NPHC's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Legal Cannabis Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Healthy Extracts Inc   70.26 %$ 1.452  Millions$ 2.067  Millions
Biote Corp   64.89 %$ 28.702  Millions$ 44.232  Millions
Niagen Bioscience Inc   64.84 %$ 19.314  Millions$ 29.785  Millions
Trulieve Cannabis Corp.  59.90 %$ 162.289  Millions$ 270.952  Millions
Functional Brands Inc.  59.89 %$ 1.120  Millions$ 1.871  Millions
Adia Nutrition, Inc.  58.22 %$ 0.283  Millions$ 0.485  Millions
Jushi Holdings Inc.  44.22 %$ 31.530  Millions$ 71.297  Millions
Ascend Wellness Holdings, Inc.  36.07 %$ 45.491  Millions$ 126.118  Millions
Tilray Brands Inc   32.13 %$ 90.521  Millions$ 281.714  Millions
Charlie s Holdings Inc   29.41 %$ 1.118  Millions$ 3.802  Millions
Nutra Pharma Corp   26.60 %$ 0.009  Millions$ 0.034  Millions
Cronos Group Inc   23.02 %$ 28.451  Millions$ 123.604  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.